Reply

Eric Morris Bomberg; Oppong Yaw Addo; Kyriakie Sarafoglou; Bradley Scott Miller

doi:10.1016/j.jpeds.2021.06.013

Reply

Pediatric Endocrinology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	329-331
Number of pages	3
Journal	Journal of Pediatrics
Volume	236
DOIs	https://doi.org/10.1016/j.jpeds.2021.06.013
State	Published - Sep 1 2021

Bibliographical note

Funding Information:
Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award K23DK125668 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding Information:
E.B. is a site principal investigator for Novo Nordisk. B.M. is a consultant for AbbVie, Ascendis, BioMarin, Bluebird Bio, Endo Pharmaceuticals, Novo Nordisk, Pfizer, Sandoz, Sanofi Genzyme, Tolmar, and Vertice and has received research support from Alexion , AbbVie , Amgen , Ascendis , BioMarin , Novo Nordisk , Opko , Protalix , Sandoz , Sangamo , Sanofi Genzyme , and Takeda . K.S. receives research support from the Federal Food and Drug Administration , National Cancer Institute , National Science Foundation , Spruce Biosciences , Alexion , and Neurocrine.

Funding Information:
E.B. is a site principal investigator for Novo Nordisk. B.M. is a consultant for AbbVie, Ascendis, BioMarin, Bluebird Bio, Endo Pharmaceuticals, Novo Nordisk, Pfizer, Sandoz, Sanofi Genzyme, Tolmar, and Vertice and has received research support from Alexion, AbbVie, Amgen, Ascendis, BioMarin, Novo Nordisk, Opko, Protalix, Sandoz, Sangamo, Sanofi Genzyme, and Takeda. K.S. receives research support from the Federal Food and Drug Administration, National Cancer Institute, National Science Foundation, Spruce Biosciences, Alexion, and Neurocrine.Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award K23DK125668. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1016/j.jpeds.2021.06.013

Find It

Find It at U of M Libraries

Cite this

@article{2e838882012346e7b06b614db5ebfdc6,

title = "Reply",

author = "Bomberg, \{Eric Morris\} and Addo, \{Oppong Yaw\} and Kyriakie Sarafoglou and Miller, \{Bradley Scott\}",

note = "Funding Information: Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award K23DK125668 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: E.B. is a site principal investigator for Novo Nordisk. B.M. is a consultant for AbbVie, Ascendis, BioMarin, Bluebird Bio, Endo Pharmaceuticals, Novo Nordisk, Pfizer, Sandoz, Sanofi Genzyme, Tolmar, and Vertice and has received research support from Alexion , AbbVie , Amgen , Ascendis , BioMarin , Novo Nordisk , Opko , Protalix , Sandoz , Sangamo , Sanofi Genzyme , and Takeda . K.S. receives research support from the Federal Food and Drug Administration , National Cancer Institute , National Science Foundation , Spruce Biosciences , Alexion , and Neurocrine. Funding Information: E.B. is a site principal investigator for Novo Nordisk. B.M. is a consultant for AbbVie, Ascendis, BioMarin, Bluebird Bio, Endo Pharmaceuticals, Novo Nordisk, Pfizer, Sandoz, Sanofi Genzyme, Tolmar, and Vertice and has received research support from Alexion, AbbVie, Amgen, Ascendis, BioMarin, Novo Nordisk, Opko, Protalix, Sandoz, Sangamo, Sanofi Genzyme, and Takeda. K.S. receives research support from the Federal Food and Drug Administration, National Cancer Institute, National Science Foundation, Spruce Biosciences, Alexion, and Neurocrine.Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award K23DK125668. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",

year = "2021",

month = sep,

day = "1",

doi = "10.1016/j.jpeds.2021.06.013",

language = "English (US)",

volume = "236",

pages = "329--331",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Reply

AU - Bomberg, Eric Morris

AU - Addo, Oppong Yaw

AU - Sarafoglou, Kyriakie

AU - Miller, Bradley Scott

N1 - Funding Information: Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award K23DK125668 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: E.B. is a site principal investigator for Novo Nordisk. B.M. is a consultant for AbbVie, Ascendis, BioMarin, Bluebird Bio, Endo Pharmaceuticals, Novo Nordisk, Pfizer, Sandoz, Sanofi Genzyme, Tolmar, and Vertice and has received research support from Alexion , AbbVie , Amgen , Ascendis , BioMarin , Novo Nordisk , Opko , Protalix , Sandoz , Sangamo , Sanofi Genzyme , and Takeda . K.S. receives research support from the Federal Food and Drug Administration , National Cancer Institute , National Science Foundation , Spruce Biosciences , Alexion , and Neurocrine. Funding Information: E.B. is a site principal investigator for Novo Nordisk. B.M. is a consultant for AbbVie, Ascendis, BioMarin, Bluebird Bio, Endo Pharmaceuticals, Novo Nordisk, Pfizer, Sandoz, Sanofi Genzyme, Tolmar, and Vertice and has received research support from Alexion, AbbVie, Amgen, Ascendis, BioMarin, Novo Nordisk, Opko, Protalix, Sandoz, Sangamo, Sanofi Genzyme, and Takeda. K.S. receives research support from the Federal Food and Drug Administration, National Cancer Institute, National Science Foundation, Spruce Biosciences, Alexion, and Neurocrine.Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award K23DK125668. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PY - 2021/9/1

Y1 - 2021/9/1

UR - https://www.scopus.com/pages/publications/85109434155

UR - https://www.scopus.com/pages/publications/85109434155#tab=citedBy

U2 - 10.1016/j.jpeds.2021.06.013

DO - 10.1016/j.jpeds.2021.06.013

M3 - Letter

C2 - 34129870

AN - SCOPUS:85109434155

SN - 0022-3476

VL - 236

SP - 329

EP - 331

JO - Journal of Pediatrics

JF - Journal of Pediatrics

ER -

Reply

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this